Influence of Co-Vid 19 Pandemic on Screening Mammography Single Institution

Chen-Pin Chou

Status: Unknown

Conditions: COVID-19; Breast Cancer

Treatments: Other: surgery

Study type: Observational

Funder types: Other

Identifiers

NCT04750018

KSVGH20-CT7-26

Details and patient eligibility

About

To assess whether the COVID-19 pandemic delayed breast cancer diagnosis in Taiwan, an Asian country with a low COVID-19 incidence.

Full description

The institutional review board approved this retrospective study at a public academic medical center. The monthly volume of breast biopsies and breast cancers during the COVID-19 pandemic (between January 1 and July 31, 2020) was compared to the same period a year earlier (pre-COVID-19).

Enrollment: 600 estimated patients

Sex: Female

Ages: 30 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Receiving breast exam 2019-2020

Exclusion criteria

• lost clinical follow-up

Trial design

600 participants in 2 patient groups

COVID-19 2019

Description:

Patients receiving biopsies with a BI-RADS assessment of 4 or 5 from mammographic or ultrasonographic exams or combinations of tests were analyzed \[4\]. We further categorized the biopsy data as ultrasound-guided or mammograph-guided biopsy based on procedure coding. Ultrasound-guided core needle biopsy (CNB) was performed for breast lesions visible on ultrasound.

COVID-19 2020

Description:

Patients receiving biopsies with a BI-RADS assessment of 4 or 5 from mammographic or ultrasonographic exams or combinations of tests were analyzed \[4\]. We further categorized the biopsy data as ultrasound-guided or mammograph-guided biopsy based on procedure coding. Ultrasound-guided core needle biopsy (CNB) was performed for breast lesions visible on ultrasound.

Treatment:

Other: surgery